Connect with us

Hi, what are you looking for?

Wednesday, Jun 25, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "Exelixis"

Citi boosts share target for ArriVent BioPharma by US$4 on positive trial data

Citi boosts share target for ArriVent BioPharma by US$4 on positive trial data

Medical and Pharmaceutical

Citi boosts share target for ArriVent BioPharma by US$4 on positive trial data

The biotech operator's lung cancer drug enabled 16-month progression-free survival among patients

Rowan Dunne1 day ago

More Posts